-
3501“…Hypercalcemia is a common complication of many granulomatous diseases but is not typically associated with leishmaniasis. Here we report an unusual case of hypercalcemia during the initiation of antiviral therapy in a patient with acquired immunodeficiency syndrome coinfected with visceral leishmaniasis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3502“…Leishmaniasis is a vector-borne disease transmitted by bites of phlebotomine sand flies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3503por Cota, Gláucia Fernandes, Gomes, Luciana Inácia, Pinto, Bruna Fernandes, Santos-Oliveira, Joanna R., Da-Cruz, Alda Maria, Pedrosa, Moisés Salgado, Tafuri, Wagner Luiz, Rabello, Ana“…This case report describes an atypical clinical presentation of visceral leishmaniasis affecting the digestive tract and causing malabsorption syndrome in a patient without recognized immunosuppressive condition. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3504“…BACKGROUND: Leishmaniasis is a major worldwide public health problem with about two to three million humans threatened by this disease annually. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3505por Nicolas, Gregory, Koury, Elliott, Osman, Dani, Salibi, Christian, Nehme, Lea, Mitri, Stephanie, Sayegh, Julien-Sami Atef El, Rached, Linda, Khoury, George“…Leishmaniasis manifests in 3 different forms: Visceral (also known as Kala Azar), which is the most serious type; cutaneous, which is the most common type; and mucocutaneous. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3506por Dorsey, Benjamin M., Cass, Cynthia L., Cedeño, David L., Vallejo, Ricardo, Jones, Marjorie A.“…Leishmaniasis is a neglected tropical disease with 1.6 million new cases reported each year. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3507“…Leishmaniasis is a neglected tropical disease caused by members of the Leishmania genus of parasitic protozoa that cause different clinical manifestations of the disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3508por Branco Santos, Joice Castelo, de Melo, Jonathas Alves, Maheshwari, Sweta, de Medeiros, Wendy Marina Toscano Queiroz, de Freitas Oliveira, Johny Wysllas, Moreno, Cláudia Jassica, Mario Amzel, L., Gabelli, Sandra B., Sousa Silva, Marcelo“…Neglected tropical diseases such as Chagas disease and leishmaniasis affect millions of people around the world. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3509por Kholoud, Kahime, Bounoua, Lahouari, Sereno, Denis, El Hidan, MoulayAbdelomain, Messouli, Mohamed“…The dissemination of anthroponotic cutaneous leishmaniasis (ACL) was related to an increase in human travel and local tourism during the studied decades. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3510“…Leishmaniasis is a vectorborne disease that can infect humans, dogs, and other mammals. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3511“…ABSTRACT: Many different animal models are in use for drug development for leishmaniasis, but a universal model does not exist. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3512por Dey, Ranadhir, Alshaweesh, Jalal, Singh, Kamaleshwar P., Lypaczewski, Patrick, Karmakar, Subir, Klenow, Laura, Paulini, Kayla, Kaviraj, Swarnendu, Kamhawi, Shaden, Valenzuela, Jesus G., Singh, Sanjay, Hamano, Shinjiro, Satoskar, Abhay R., Gannavaram, Sreenivas, Nakhasi, Hira L., Matlashewski, Greg“…Using a mouse model of cutaneous leishmaniasis and a hamster model of visceral leishmaniasis, soluble antigen induces a leishmanin skin test response following infection and vaccination with live attenuated Leishmania major (LmCen(-/-)). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3513“…Leishmaniasis shows clinical changes such as subclinical, localized (cutaneous leishmaniasis), or widespread infection (cutaneous, mucosal, or visceral), depending on the parasite and host factors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3514“…BACKGROUND: Chemotherapy is still a critical issue in the management of leishmaniasis. Until recently, pentavalent antimonials, amphotericin B or pentamidine compounded the classical arsenal of treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3515por Santos-Oliveira, Joanna R, Giacoia-Gripp, Carmem BW, Alexandrino de Oliveira, Priscilla, Amato, Valdir S, Lindoso, Jose Ângelo L, Goto, Hiro, Oliveira-Neto, Manoel P, Mattos, Marise S, Grinsztejn, Beatriz, Morgado, Mariza G, Da-Cruz, Alda M“…We investigated whether leishmaniasis increases lymphocyte activation in HIV-1 co-infected patients. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3516por Wege, Anja Kathrin, Florian, Christian, Ernst, Wolfgang, Zimara, Nicole, Schleicher, Ulrike, Hanses, Frank, Schmid, Maximilian, Ritter, Uwe“…BACKGROUND: Leishmania (L.) species are the causative agent of leishmaniasis. Due to the lack of efficient vaccine candidates, drug therapies are the only option to deal with cutaneous leishmaniasis. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3517por Majumder, Saikat, Bhattacharjee, Surajit, Paul Chowdhury, Bidisha, Majumdar, Subrata“…The visceral form of leishmaniasis is the most severe form of the disease and of particular concern due to the emerging problem of HIV/visceral leishmaniasis (VL) co-infection in the tropics. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3518“…Visceral leishmaniasis (VL), also called Kala Azar (KA) or black fever in India, claims around 20,000 lives every year. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3519por Zahedifard, Farnaz, Gholami, Elham, Taheri, Tahereh, Taslimi, Yasaman, Doustdari, Fatemeh, Seyed, Negar, Torkashvand, Fatemeh, Meneses, Claudio, Papadopoulou, Barbara, Kamhawi, Shaden, Valenzuela, Jesus G., Rafati, Sima“…The nonpathogenic to humans lizard protozoan parasite, Leishmania (L) tarentolae, has been used effectively as a vaccine platform against visceral leishmaniasis in experimental animal models. Correspondingly, pre-exposure to sand fly saliva or immunization with a salivary protein has been shown to protect mice against cutaneous leishmaniasis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3520por Ravooru, Nithin, Ganji, Sandesh, Sathyanarayanan, Nitish, Nagendra, Holenarsipur G.“…Leishmaniasis is a parasitic disease caused by the protozoan Leishmania, which is active in two broad forms namely, Visceral Leishmaniasis (VL or Kala Azar) and Cutaneous Leishmaniasis (CL). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto